Preclinical Contract Research

(Image: Getty/unoL)

PE firm picks up model provider Taconic

By Melissa Fassbender

Backed by a private equity investment, Taconic Biosciences is focusing on its growth strategy, with plans to add capacity, pursue acquisitions, and develop new products, says the company’s new CEO.

(Image: Getty/NicoElNino)

New AI tech reduces research bottlenecks

By Maggie Lynch

The new technology, Pattern to Knowledge (P2K), reduces “bottlenecks” in drug research by examining bio-sequences in a shorter time frame.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers